Pathologic Stage III Gastric Cancer AJCC v8
generalStage IIIA includes: (T2, N3a, M0); (T3, N2, M0); (T4a, N1, M0); (T4a, N2, M0); (T4b, N0, M0). T2: Tumor invades the muscularis propria. T3: Tumor penetrates the subserosal connective tissue without invasion of the visceral peritoneum or adjacent structures. T4a: Tumor invades the serosa (visceral peritoneum). T4b: Tumor invades adjacent structures/organs. N0: No regional lymph node metastasis. N1: Tumor with metastasis in one or two regional lymph nodes. N2: Tumor with metastasis in three to s
11
Centers
11
Active Trials
—
Cancer Funding
Top Centers for Pathologic Stage III Gastric Cancer AJCC v8(11)
Ranked by research excellence score (trials · grants · publications). Methodology →
| # | Center | Score |
|---|---|---|
| 1 | Mayo Clinic Comprehensive Cancer CenterRochester, MN NCI Comprehensive Active Research Program | 54.5 |
| 2 | Vanderbilt-Ingram Cancer CenterNashville, TN NCI Comprehensive Active Research Program | 54.5 |
| 3 | Winship Cancer InstituteAtlanta, GA NCI Comprehensive Active Research Program | 54.5 |
| 4 | USC Norris Comprehensive Cancer CenterLos Angeles, CA NCI Comprehensive Active Research Program | 54.5 |
| 5 | Cleveland Clinic Cancer CenterCleveland, OH Active Research Program | 54.5 |
| 6 | Holden Comprehensive Cancer CenterIowa City, IA NCI Comprehensive Active Research Program | 54.5 |
| 7 | Fred & Pamela Buffett Cancer CenterOmaha, NE NCI Clinical Active Research Program | 54.5 |
| 8 | University of Illinois Cancer CenterChicago, IL Active Research Program | 54.5 |
| 9 | Cancer Center at IllinoisUrbana, IL Active Research Program | 54.5 |
| 10 | Mayo Clinic Comprehensive Cancer Center, FloridaJacksonville, FL Active Research Program | 54.5 |
| 11 | Mayo Clinic Comprehensive Cancer Center, ArizonaScottsdale, AZ Active Research Program | 54.5 |
Research tier badges reflect trial volume, NIH grant funding, and publication impact — not clinical outcomes or patient satisfaction. Learn about our methodology →